Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Hugh M. Jones |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Optimizing limbic selective d2/d3 receptor occupancy by risperidone: a [123i]-epidepride spet study / Rodrigo A. Bressan en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 1 (Febrero)
[artículo]
Título : Optimizing limbic selective d2/d3 receptor occupancy by risperidone: a [123i]-epidepride spet study Tipo de documento: texto impreso Autores: Rodrigo A. Bressan, Autor ; Kjell Erlandsson, Autor ; Hugh M. Jones, Autor Fecha de publicación: 2023 Artículo en la página: pp. 5-14 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Sistema Límbico, Sistema límbico, Pirrolidinas, Receptores de dopamina D2, Risperidona, Esquizofrenia. Resumen: Selective action at limbic cortical dopamine D2-like receptors is a putative mechanism of atypical antipsychotic efficacy with few extrapyramidal side effects. Although risperidone is an atypical antipsychotic with high affinity for D2 receptors, low-dose risperidone treatment is effective without inducing extrapyramidal symptoms. Link: ./index.php?lvl=notice_display&id=31038
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 5-14[artículo] Optimizing limbic selective d2/d3 receptor occupancy by risperidone: a [123i]-epidepride spet study [texto impreso] / Rodrigo A. Bressan, Autor ; Kjell Erlandsson, Autor ; Hugh M. Jones, Autor . - 2023 . - pp. 5-14.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 5-14
Palabras clave: Antipsicóticos, Sistema Límbico, Sistema límbico, Pirrolidinas, Receptores de dopamina D2, Risperidona, Esquizofrenia. Resumen: Selective action at limbic cortical dopamine D2-like receptors is a putative mechanism of atypical antipsychotic efficacy with few extrapyramidal side effects. Although risperidone is an atypical antipsychotic with high affinity for D2 receptors, low-dose risperidone treatment is effective without inducing extrapyramidal symptoms. Link: ./index.php?lvl=notice_display&id=31038